Detalhe da pesquisa
1.
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
N Engl J Med
; 385(9): 777-789, 2021 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351722
2.
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
N Engl J Med
; 385(9): 790-802, 2021 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351721
3.
Strategy to optimize PeriproCeduraL AnticOagulation in structural transseptal interventions: Design and rationale of the STOP CLOT trial.
Am Heart J
; 271: 68-75, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38401649
4.
Impact of omitting the intravenous heparin bolus on outcomes of leadless pacemaker implantation.
J Cardiovasc Electrophysiol
; 35(6): 1212-1216, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38650520
5.
Antithrombin Levels and Heparin Responsiveness during Venoarterial Extracorporeal Membrane Oxygenation: A Prospective Single-center Cohort Study.
Anesthesiology
; 140(6): 1153-1164, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38271619
6.
Comparison of Outcomes in Patients Requiring Mechanical Circulatory Support Who Received Cangrelor in Addition to Anticoagulation Versus Anticoagulation Alone.
J Cardiothorac Vasc Anesth
; 38(6): 1328-1336, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38521630
7.
Agreement between the thromboelastography reaction time parameter using fresh and citrated whole blood during extracorporeal membrane oxygenation with Teg®5000 and Teg®6s.
Perfusion
; 39(1_suppl): 77S-80S, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38651576
8.
Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial.
Lancet
; 399(10319): 50-59, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34921756
9.
Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study.
Blood
; 136(3): 328-338, 2020 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32321172
10.
Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies.
Inflamm Res
; 71(1): 39-56, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34802072
11.
An ex vivo comparison of partial thromboplastin time and activated clotting time for heparin anticoagulation in an ovine model.
Artif Organs
; 46(3): 501-505, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34698388
12.
Conventional versus restricted anti-Xa-guided heparin protocol in adult patients undergoing extracorporeal membrane oxygenation.
Artif Organs
; 46(1): 128-137, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34725832
13.
Endotoxin Adsorbent Therapy in Severe COVID-19 Pneumonia.
Blood Purif
; 51(1): 47-54, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-33857940
14.
Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
JAMA
; 327(3): 227-236, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35040887
15.
Weekly injection of IL-2 using an injectable hydrogel reduces autoimmune diabetes incidence in NOD mice.
Diabetologia
; 64(1): 152-158, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33125521
16.
Surface Glycan Modification of Cellular Nanosponges to Promote SARS-CoV-2 Inhibition.
J Am Chem Soc
; 143(42): 17615-17621, 2021 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34647745
17.
Optimal protamine dosing after cardiopulmonary bypass: The PRODOSE adaptive randomised controlled trial.
PLoS Med
; 18(6): e1003658, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34097705
18.
The heparin-von Willebrand factor interaction and conventional tests of haemostasis - the challenges in predicting bleeding in cardiopulmonary bypass.
Br J Haematol
; 192(6): 1073-1081, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33278841
19.
Coupling Liquid Chromatography and Tandem Mass Spectrometry to Electrophoresis for In-Depth Analysis of Glycosaminoglycan Drugs: Heparin and the Multicomponent Sulodexide.
Anal Chem
; 93(3): 1433-1442, 2021 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33369405
20.
Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia.
Blood
; 133(22): 2427-2435, 2019 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30917957